1. Home
  2. LASE vs SCYX Comparison

LASE vs SCYX Comparison

Compare LASE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASE
  • SCYX
  • Stock Information
  • Founded
  • LASE 2019
  • SCYX 1999
  • Country
  • LASE United States
  • SCYX United States
  • Employees
  • LASE N/A
  • SCYX N/A
  • Industry
  • LASE Industrial Machinery/Components
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASE Industrials
  • SCYX Health Care
  • Exchange
  • LASE Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • LASE 27.1M
  • SCYX 28.5M
  • IPO Year
  • LASE 2022
  • SCYX 2014
  • Fundamental
  • Price
  • LASE $3.88
  • SCYX $0.70
  • Analyst Decision
  • LASE
  • SCYX
  • Analyst Count
  • LASE 0
  • SCYX 0
  • Target Price
  • LASE N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • LASE 375.5K
  • SCYX 138.2K
  • Earning Date
  • LASE 07-07-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • LASE N/A
  • SCYX N/A
  • EPS Growth
  • LASE N/A
  • SCYX N/A
  • EPS
  • LASE N/A
  • SCYX N/A
  • Revenue
  • LASE $4,962,487.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • LASE N/A
  • SCYX $463.61
  • Revenue Next Year
  • LASE N/A
  • SCYX $310.80
  • P/E Ratio
  • LASE N/A
  • SCYX N/A
  • Revenue Growth
  • LASE 23.87
  • SCYX N/A
  • 52 Week Low
  • LASE $1.58
  • SCYX $0.66
  • 52 Week High
  • LASE $19.80
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • LASE 73.18
  • SCYX 38.69
  • Support Level
  • LASE $2.34
  • SCYX $0.67
  • Resistance Level
  • LASE $2.76
  • SCYX $0.75
  • Average True Range (ATR)
  • LASE 0.28
  • SCYX 0.04
  • MACD
  • LASE 0.15
  • SCYX 0.00
  • Stochastic Oscillator
  • LASE 95.23
  • SCYX 33.06

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: